Ketosis-Prone Type 2 Diabetes (Flatbush Diabetes) in Remission: A Report of Two Cases

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Oct 3

PMID 36185931

Authors

Beisi Ji

SumathaChannapatna Suresh

Klynt Bally

Kamrun Naher

Mary A Banerji

Affiliations

Soon will be listed here.

Abstract

Diabetic ketoacidosis (DKA) is a triad of uncontrolled hyperglycemia, metabolic acidosis, and increased total body ketone concentration. It is a well-known manifestation of type 1 diabetes mellitus (T1DM). However, it can also be the first presentation of type 2 diabetes mellitus (T2DM). This subtype of diabetes shares the characteristics of both T1DM and T2DM and is called 'Flatbush diabetes,' also known as 'ketosis-prone T2DM.' This article highlights the importance of early identification of ketosis-prone T2DM (KPD). We describe two cases of African American men with no past medical histories who presented with unproved DKA as the first presentation of T2DM requiring initial intensive insulin therapy, which was gradually withdrawn with the addition of metformin. Both patients are currently insulin independent for more than 15 months. It is an essential clinical entity to recognize as insulin independence positively impacts the quality of life and decreases the economic burden on the health care system.

References

Rewers M . Challenges in diagnosing type 1 diabetes in different populations. Diabetes Metab J. 2012; 36(2):90-7. PMC: 3335902. DOI: 10.4093/dmj.2012.36.2.90. View

Balasubramanyam A, Nalini R, Hampe C, Maldonado M . Syndromes of ketosis-prone diabetes mellitus. Endocr Rev. 2008; 29(3):292-302. PMC: 2528854. DOI: 10.1210/er.2007-0026. View

Umpierrez G, Clark W, Steen M . Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Diabetes Care. 1997; 20(4):479-83. DOI: 10.2337/diacare.20.4.479. View

Maldonado M, Otiniano M, Cheema F, Rodriguez L, Balasubramanyam A . Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved beta-cell function. Diabet Med. 2006; 22(12):1744-50. DOI: 10.1111/j.1464-5491.2005.01724.x. View

Umpierrez G, Smiley D, Kitabchi A . Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006; 144(5):350-7. DOI: 10.7326/0003-4819-144-5-200603070-00011. View

Maldonado M, Hampe C, Gaur L, DAmico S, Iyer D, Hammerle L . Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab. 2003; 88(11):5090-8. DOI: 10.1210/jc.2003-030180. View

Winter W, Maclaren N, Riley W, CLARKE D, KAPPY M, Spillar R . Maturity-onset diabetes of youth in black Americans. N Engl J Med. 1987; 316(6):285-91. DOI: 10.1056/NEJM198702053160601. View

Lebovitz H, Banerji M . Ketosis-Prone Diabetes (Flatbush Diabetes): an Emerging Worldwide Clinically Important Entity. Curr Diab Rep. 2018; 18(11):120. PMC: 6182625. DOI: 10.1007/s11892-018-1075-4. View

Maldonado M, Otiniano M, Lee R, Rodriguez L, Balasubramanyam A . Ethnic differences in beta-cell functional reserve and clinical features in patients with ketosis-prone diabetes. Diabetes Care. 2003; 26(8):2469. DOI: 10.2337/diacare.26.8.2469. View

10.

Nalini R, Ozer K, Maldonado M, Patel S, Hampe C, Guthikonda A . Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection. Metabolism. 2010; 59(10):1448-55. PMC: 2888957. DOI: 10.1016/j.metabol.2010.01.009. View

11.

Sjoholm A . Ketosis-Prone Type 2 Diabetes: A Case Series. Front Endocrinol (Lausanne). 2019; 10:684. PMC: 6843078. DOI: 10.3389/fendo.2019.00684. View

12.

Banerji M, Chaiken R, Lebovitz H . Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes. 1995; 44(4):466-70. DOI: 10.2337/diab.44.4.466. View

13.

Safder S, Mortada R . Diabetes 1.5: Ketone-Prone Diabetes. Clin Diabetes. 2015; 33(3):150-1. PMC: 4503942. DOI: 10.2337/diaclin.33.3.150. View